ArticleCancer research2014

Kinase domain activation of FGFR2 yields high-grade lung adenocarcinoma sensitive to a Pan-FGFR inhibitor in a mouse model of NSCLC.

Jeremy H Tchaicha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.